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Abstract
Introduction: Cardiovascular disease is the leading cause of death in women. 
Observational studies suggest that women with a history of recurrent miscarriage 
have an increased risk of cardiovascular disease.
Material and methods: Women who visited the recurrent miscarriage clinic at Leiden 
University Medical Center between 2000 and 2010 and who had their third consecu-
tive miscarriage before the age of 31 years, were invited to participate in this follow-
 up study (between 2012 and 2014). The reference group consisted of women with at 
least one uncomplicated pregnancy and no miscarriage, matched by zip code, age, and 
date of pregnancy. All women were invited for risk factor screening, including physical 
examination and blood collection. Main outcome measures were the (extrapolated) 
10- and 30- year cardiovascular risk scores using the Framingham risk score. A suba-
nalysis was performed for women with idiopathic recurrent miscarriage.
Results: Thirty- six women were included in both groups. Mean follow up was 
7.5 years. Women with recurrent miscarriage had a significantly higher extrapolated 
10- year cardiovascular risk score (mean 6.24%, SD 5.44) compared with women with 
no miscarriage (mean 3.56%, SD 1.82, P = .007) and a significantly higher 30- year 
cardiovascular risk score (mean 9.86%, SD 9.10) compared with women with no mis-
carriage (mean 6.39%, SD 4.20, P = .04). Similar results were found in women with 
idiopathic recurrent miscarriage (n = 28).
Conclusions: Women with a history of recurrent miscarriage differ in cardiovascular 
risk profile at a young age compared with women with no miscarriage. The findings 
support an opportunity to identify women at risk of cardiovascular disease later in 
life and a possible moment for intervention.
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1  | INTRODUC TION
Cardiovascular disease (CVD) is the leading cause of death in women 
in the Western world.1 Women have a unique risk profile for CVD 
compared with men.2 Pregnancy can be considered a “stress test” 
unmasking underlying cardiovascular defects.3 A history of gesta-
tional diabetes, preeclampsia or pregnancy- induced hypertension is 
mentioned as a major risk factor in women for developing CVD in 
the American Heart Association Guidelines.2 Miscarriages are not 
considered in that guideline.
Recurrent miscarriage (RM) is commonly defined as 3 or more 
consecutive pregnancy losses before 22 weeks of gestation 4 and 
affects 0.5%- 3% of all fertile couples.5 Observational studies sug-
gest that women with a history of RM also have an increased risk 
of CVD.6–9 Several hypotheses are possible for the association be-
tween both diseases; shared common risk factors such as obesity 
and smoking,10 endothelial dysfunction,11 and a genetic predisposi-
tion is assumed.12
We hypothesize that women with a history of RM have a more 
unfavorable cardiovascular risk profile already at a young age com-
pared with women with no miscarriage. If so, women with RM repre-
sent an ideal target population for preventive strategies. Worldwide 
multivariable risk assessment tools have been developed to detect 
apparently healthy individuals at high risk for CVD.13 At present the 
most common externally validated risk model is the Framingham risk 
score.14
A follow- up study was conducted to determine cardiovascular 
risk factors and predict the long- term CVD risk using Framingham 
risk scores in women with a history of RM.




Women who visited the RM clinic at Leiden University Medical 
Center between 2000 and 2010 and had their third consecutive 
miscarriage below the age of 31 years were invited to participate 
in this follow- up study. RM was defined as ≥3 consecutive miscar-
riages before 22 weeks of gestation. All women had a routine RM 
work- up to identify possible causes of the RM: a standardized his-
tory of the couple was performed, karyotyping of the couple (this 
was offered routinely before 2005 to all couples and after 2005 
only in the presence of low maternal age and/or positive family 
history for RM),15 presence of uterine anomalies by ultrasound or 
hysteroscopy, and presence of acquired and heritable thrombo-
philia were assessed. For acquired thrombophilia, antiphospholipid 
syndrome was defined as the presence of anticardiolipin antibod-
ies or lupus anticoagulant in repeated samples taken 3 months 
apart and at least 10 weeks after delivery;16 after revision of the 
classification criteria, the presence of anti- β2 glycoprotein- I was 
added to the work- up.17 Hyperhomocysteinemia was evaluated. 
Heritable thrombophilia was defined by the presence of a factor 
V Leiden mutation, factor II (prothrombin) gene mutation, protein 
C or S deficiency or antithrombin deficiency. Women with primary 
miscarriage (no live birth before miscarriage) and secondary miscar-
riage (live births before miscarriage) were included. The time inter-
val between the RM diagnosis and the time of follow up had to be 
at least 2 years.
2.3 | Unexposed
Women with one or more uncomplicated pregnancy(ies) and no 
miscarriages were enrolled (reference group). In the Netherlands, 
it is common practice that independent community midwives take 
care of low- risk women (with no medical or obstetrical history) 
during pregnancy and childbirth. The zip code of each woman 
with RM was used to contact the nearest midwifery practice to 
take the impact of socioeconomic status into account. Women 
with the same zip code and the same age (difference in birth date 
a maximum of 1 year) and for whom the time of first delivery 
was close to the time of the third miscarriage of the matched 
exposed woman (maximum 6 months before or 6 months after) 
were asked to participate. Women with RM were included in the 
study before the matched controls were invited to participate; 
a small difference in follow- up time was therefore expected. 
In both groups, pregnant and lactating women (within the last 
3 months) were excluded. Enrollment took place between 2012 
and 2014.
2.4 | Procedures and definitions
After enrollment, all women were asked to fill out a web- based 
questionnaire and were invited for risk factor screening. The 
questionnaire covered general information, medical history, 
family history of CVD, use of medication, intoxications, and ob-
stetric history. Information about medical history, use of medi-
cation, intoxications, and pregnancy outcome was cross- checked 
in obstetrical records to overcome recall bias. Gestational 
diabetes was defined as a glucose intolerance resulting in hy-
perglycemia with onset during pregnancy.18 Preeclampsia was 
defined as systolic blood pressure above 140 mm Hg and/or di-
astolic pressure above 90 mm Hg combined with proteinuria;19 
Key Message
An increased cardiovascular disease risk was found in 
women with a history of recurrent miscarriage compared 
with women with no miscarriages. Our results support an 
opportunity to identify women at increased risk of future 
cardiovascular disease early in life.
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pregnancy- induced hypertension as systolic blood pressure 
above 140 mm Hg and/or diastolic pressure above 90 mm Hg 
or higher measured on 2 occasions (after 20 weeks of gesta-
tion);20 and preterm birth as a delivery before 37 weeks of 
gestation, intrauterine growth restriction as birthweight below 
the 10th percentile for gestational age and sex according to 
the Netherlands Perinatal Registry birthweight percentiles.21 
Assessment of classic cardiovascular risk factors was performed 
by trained research nurses or doctors at the Leiden University 
Medical Center or at the participants’ home. Blood pressure was 
measured manually in sitting position with a validated sphyg-
momanometer on the left upper arm with the appropriate cuff 
size; the mean of 2 measurements was taken. Length and weight 
was measured wearing light clothes and without shoes; length 
was measured to the nearest 1 cm and weight to the nearest 
1 kg. Body mass index (BMI) was calculated as weight/length2, 
venous blood samples were collected after an overnight fast and 
assayed for classical risk factors of CVD (glucose, insulin, hemo-
globin A1c [HbA1c], total cholesterol, high- density lipoprotein 
[HDL] cholesterol, triglycerides). Insulin resistance was assessed 
by the homeostasis model assessment.22 The blood samples 
were centrifuged, separated, and frozen at −80°C within 2 hours. 
Routine chemistry analyses were performed on a Roche Modular 
P800 chemistry analyzer using reagents of Roche Diagnostics 
(Mannheim, Germany). Analytical variation of all analytes was 
well below 5%. Insulin was analyzed on an Immulite 2000 Xpi im-
munoanalyzer (Siemens Healthcare Diagnostics; Tarrytown, NY, 
USA). Analytical variation varied between 5% and 8%. HbA1c 
was analyzed using a Boronate affinity chromatographic system 
(Primus Ultra2, Trinity Biotech, Bray, Ireland). Analytical varia-
tion was well below 2%. All analyses were performed by techni-
cians blinded for obstetrical history. Family history of premature 
myocardial infarction and/or stroke was defined as having at 
least one parent with myocardial infarction and/or stroke before 
the age of 60 years.
The 10- and 30- year CVD risk by the Framingham score23,24 
was calculated using information on age, systolic blood pressure, 
antihypertensive treatment, smoking, diabetes, and lipid spectrum 
(total cholesterol and HDL cholesterol) or BMI (a simpler model of 
the risk score). Both models, using lipids and using BMI, were ap-
plied. CVD was defined as coronary death, myocardial infarction, 
coronary insufficiency, angina pectoris, ischemic stroke, hemor-
rhagic stroke, transient ischemic attack, peripheral artery disease, 
or heart failure. The 10- year CVD risk score was calculated twice, 
once using current age and subsequently estimating the risk as 
if the woman was 60 years of age (due to the young age of our 
participants, the estimated absolute 10- year CVD risk was likely 
to be low). This approach has been recommended in the cardio-
vascular risk factor management guidelines for young women with 
elevated risk factor levels.25 The risk estimation was repeated in a 
subgroup analysis including women with idiopathic RM. RM was 
defined as idiopathic when the work- up for causes of RM showed 
no abnormalities.
2.5 | Sample size considerations
The calculation was based on results of the Hyras study: the (extrap-
olated) 10- year CVD risk was 4.4% (SD 1.9) in women with uncompli-
cated pregnancies.26 We planned to include women in 1:1 ratio, that 
is, a woman who had RM matched to one control. A relative risk of 
1.5 or higher was considered to be clinically relevant. A sample size 
of 68 women (34 exposed, 34 non- exposed) was sufficient, with a 
10% drop- out rate (two- sided alpha .05. power 90%).
2.6 | Statistical analyses
Data were analyzed using SPSS software version 22.0 (SPSS, 
Chicago, IL, USA). Comparisons of normal distributed data were per-
formed using paired t test. Comparisons of continuous data were 
performed using McNemar’s test. For all tests, a P- value < .05 is con-
sidered statistically significant.
2.7 | Ethical approval
Approval from the medical ethics committee of Leiden University 
Medical Center (P04- 020; 3 October 2012) was obtained and all 
participants gave informed consent. The study was registered with 
the Dutch trial registry NTR3408. This study is part of the REMI 
(REcurrent MIscarriages) studies, studies which investigate conse-
quences and causes of RM.
3  | RESULTS
A flowchart of the inclusion of the participants is shown in Figure 1. 
Thirty- six matched pairs were included.
Women with RM had a significantly higher gravidity and lower 
parity than those in the no miscarriage group (Table 1). Women with 
RM were more often smokers during pregnancy (P = .05). On all 
other variables, groups were comparable.
Of the women with RM (n = 28), 78% were diagnosed with idio-
pathic RM. Parental chromosomal abnormality was found in 1 case, 
antiphospholipid syndrome in 1 case, hyperhomocysteinemia in 3 
cases, and heritable thrombophilia in 3 cases.
Mean follow- up time was 6.8 years (SD 3.0) in women with RM 
and 8.1 years in women with no miscarriage (SD 2.9), (P < .001). 
Classical cardiovascular risk factors are described in Table 2. Women 
with RM were slightly younger at time of follow- up than women with 
no miscarriage (P < .001). Values of classical cardiovascular risk fac-
tors were higher in women with RM compared with women no mis-
carriage, although the values were only significant for systolic blood 
pressure.
Women with RM had significantly higher mean CVD risk scores 
compared with women with no miscarriage (Table 3), whether using 
the lipids or the BMI model. In the subgroup analysis including 
women with idiopathic RM, comparable results to those of the total 
group were found (Table 3).
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4  | DISCUSSION
In this follow- up study, an increased (extrapolated) 10- and 30- year 
CVD risk was found in women with a history of RM than in women 
with no miscarriages, calculated by Framingham risk scores (lipids 
and BMI model). Women with RM had an increased systolic blood 
pressure compared with women with no miscarriage at time of 
 follow up.
The Framingham risk score is the most externally validated risk 
score and is widely used in North American countries.14 It is the only 
model which can estimate the 10- and 30- year CVD risk (mortality 
and morbidity) and is therefore useful to estimate risks for a young 
population. European guidelines advise using SCORE, which as-
sesses only mortality risk and therefore is less useful in our young 
population.27 Overestimation of the risk of CVD is possible using the 
Framingham score in a European cohort.14 If so, an overestimation of 
the risk occurred in both groups and therefore would not change the 
direction of effect. Due to the young age of our participants, we cal-
culated the 10- year risk scores as if the women were 60 years of age 
according to guidelines for young women with elevated risk factor 
levels.25 The new method of “cardiovascular risk age”28 was not ap-
plicable to our young cohort (age below 40 years). A disadvantage of 
this method, extrapolating to an age of 60 years, is that the real risk 
could be underestimated, assuming that levels of cardiovascular risk 
factors will increase without prevention or intervention. Perhaps 
this is why we found quite a large difference between the extrapo-
lated 10- year CVD risk and the 30- year CVD scores in women with 
an RM mean risk of 6.24% and 9.86%, respectively.
Few studies have been performed regarding cardiovascular risk 
factors in women with RM. A summary is given in Table 4. Our find-
ings are inconsistent with the results of the study from Mahendru 
et al.,29 which found no difference in cardiovascular function and 
risk factors between women with unexplained RM and women with 
uncomplicated pregnancy. Explanations for this may be a lack of 
power, short follow- up time or a difference in the selection of the 
women with RM. Our findings are in line with the report by Germain 
et al. 11, who found an altered cardiovascular risk profile in women 
with unexplained RM compared with women with uncomplicated 
pregnancy. Their methods differed from ours, as they excluded all 
women with preexisting markers of endothelial dysfunction, intro-
ducing a high level of selection bias. The explanation for this is that 
they were investigating the hypothesis that endothelial dysfunction 
could be the link between miscarriage and CVD. We performed a 
subgroup analysis including only women with idiopathic RM (n = 28) 
(Table 3), which showed comparable results to the results of the 
total group. Therefore, in the present study, the increased risk of 
CVD in women with RM cannot be explained by the presence of 
known acquired and heritable thrombophilia.
In Table 2, we described the individual classical risk factors. Only 
systolic blood pressure was significantly higher in women with RM 
F IGURE  1 Flow chart: selection of participants. [Color figure can be viewed at wileyonlinelibrary.com]
Eligible women with recurrent 
miscarriage n = 110
Recurrent miscarriage
n = 38
Matched to women without miscarriage
Invited n = 148
Excluded from analysis 
Recurrent miscarriage: n = 2 (1 lactating, 1 non consecutive miscarriage)
No miscarriage: n = 2 (1 history of miscarriage, 1 matched to excluded woman) 






Declined to participate due to emotional reasons 
n = 17
Did not meet inclusion criteria 








Did not meet inclusion criteria (pregnant/lactating 
during study period) 
n = 10




n = 36 P- value
Maternal age at index 
pregnancya
26.36 (2.65) 26.47 (2.69) .70
Caucasian, % 32 (88.9) 30 (83.3) .63
University level education, 
%
16 (44.4) 8 (22.2) .08
Gravidity 2.28 (0.62) 7.11 (2.07) <.001
Parity 2.25 (0.60) 1.64 (0.83) .001
Primary miscarriages, % – 27 (75.0) –
At least one continuing 
pregnancy,b %
36 (100) 35 (97.2) .31
Smoking during pregnancy,c 
%
5 (13.9) 14 (38.9) .05
Gestational diabetes,c % 0 (0) 0 (0) –
Preeclampsia/gestational 
hypertension,b,c %
0 (0) 3 (8.3) .08
Preterm birth,c % 1 (2.8) 4 (11.1) .38
Intrauterine growth 
restriction,c %
4 (11.1) 4 (11.1) 1.00
Data are presented as mean (SD).
aAge at first pregnancy for unexposed women, age at third consecutive miscarriage for exposed 
women.
bChi- square test. McNemar’s test not possible (at least one variable in each two- way table is a 
constant).
cIn at least one continuing pregnancy.





n = 36 P- value
Maternal age at follow up 34.50 (3.59) 33.28 (3.51) <.001
Smoking at follow up, % 5 (13.9) 10 (27.8) .23
BMI at follow up 23.78 (3.49) 25.89 (7.08) .09
Systolic blood pressure, mm Hg 101.11 (10.72) 111.11 (13.06) <.001
Diastolic blood pressure, mm Hg 67.22 (7.62) 70.64 (9.54) .08
Antihypertensive medication 
use,a %
0 (0) 3 (8.33) .08
HOMA score 2.28 (1.95) 3.40 (6.20) .31
HbA1c, mmol/mol Hb 29.89 (2.45) 32.25 (8.36) .13
Total cholesterol, mmol/L 4.89 (0.76) 4.76 (0.68) .46
HDL cholesterol, mmol/L 1.71 (0.39) 1.59 (0.49) .25
Triglycerides, mmol/L 0.98 (0.29) 1.12 (0.61) .24





Data are presented as mean (SD).
BMI, body mass index; HbA1C, hemoglobin A1c; HOMA, homeostasis model assessment; HDL, 
high- density lipoproteins; MI, myocardial infarction.
aChi- square test. McNemar’s test not possible (at least 1 variable in each two- way table is a 
constant).
bDue to the matched analysis, the associated women with RM were excluded, leaving n = 35 in both 
groups.
TABLE  2 Classical cardiovascular risk 
factors
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compared with those with no miscarriage. Since we did not per-
form a sample size analysis based on individual risk factors, a lack 
of power is likely when investigating the individual risk factors. It 
would be interesting to investigate these risk factors in a larger study 
group. As we were only able to look at cardiovascular risk factors in 
women after they experienced RM, we cannot answer the question 
about cause and effect. Although preexisting CVD risk factors are 
associated with an increased risk of developing miscarriages, it is 
not known whether miscarriages merely unmask risk or contribute 
directly to future CVD. Miscarriages could trigger a pathophysiolog-
ical mechanism or cascade that in turn leads to CVD, potentially via 
interactions with classical risk factors.
To our knowledge this is the first study which investigated and 
calculated CVD risk scores in women with a history of RM. A strength 
of our research is the unique, well- defined cohort. RM is a highly 
heterogenic condition; to strive for more homogeneity, in the pres-
ent study we only included women who had their third consecutive 
miscarriage below the age of 31. A younger age at diagnosis makes 
a maternal cause of RM more plausible and reduces the chance of 
miscarriages due to fetal abnormalities.30 Another strength is the 
availability of a wide range of covariates in both groups (Table 1). 
Some covariates have an effect on our outcome of interest. It would 
not make sense to adjust for BMI or smoking as confounding factors, 
since both are included as variables in the risk estimation.31 On the 
other hand, it is interesting to verify whether the increased cardio-
vascular risk score in women with RM persists after adjustments for 
smoking and hypertension, or whether the results are totally depen-
dent on these variates. For this reason, we performed multivariate 
analyses including smoking and hypertension (Tables S1 and S2); we 
found that neither solely explains the increased risk.
Some women experienced a complication during pregnancy 
such as gestational diabetes and preeclampsia which may increase 
their risk of CVD later in life.2, 32 We did not adjust for a history of 
complications of pregnancy since these events may be on the causal 
pathway between miscarriage and CVD.33 If we assume that they 
are not on this pathway and that these events are confounding fac-
tors, we should have adjusted for these pregnancy complications. 
Therefore, we repeated the risk calculations for women who did not 
have a pregnancy complicated by gestational diabetes, preeclamp-
sia, pregnancy- induced hypertension, or preterm birth (Tables S1 
and S2). Women with RM (n = 30) still had a significantly higher 
extrapolated 10- year cardiovascular risk score (using lipids: mean 
5.31%, SD 3.96) compared with women with no miscarriage (mean 
3.59%, SD 1.94, P = .03). Comparable results were found in women 
with idiopathic RM (n = 24) (Tables S1 and S2). Therefore, we can 
conclude that the elevated risk scores in women with RM cannot be 
explained solely by other pregnancy complications known to be risk 
factors in women for developing CVD.
Limitations of our study should be acknowledged. The risk for 
CVD in women with RM could be underestimated due to the fol-
lowing reasons. First, selection bias may have been introduced. 
Women declined to participate for emotional reasons or did not re-
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the “worst” cases, women without a live birth, were more likely to 
decline or not respond (only 1 woman in our study group had no 
live birth). Secondly, women received lifestyle advice during their 
consultations at the RM clinic. Individual risk factors may have 
been changed, which could decrease the risk profile. Finally, the 
increased risk could be underestimated because women with RM 
were included in the study before the matched controls were in-
vited to participate, resulting in a small difference in age (1.2 years) 
at follow up, and risk factors are likely to increase with age. On the 
other hand, since the unexposed group consisted of women who 
had at least 1 uncomplicated pregnancy, this may have resulted 
in a healthier cohort compared with a population- based cohort. 
Selection bias is also possible in the unexposed group; women 
with a higher education are probably more likely to participate 
(although no significant difference was found for university- level 
education between both groups). Another limitation is the rela-
tively small sample size. A preliminary calculation was performed 
based on the 10- year risk score with age extrapolated to 60 years, 
which showed that 34 women in both groups would be sufficient. 
However, it is possible that, especially for the subgroup analyses, 
our study may be partly underpowered, and we should be cautious 
about drawing conclusions.
5  | CONCLUSION
In the present study, we show that women with a history of RM, 
whether idiopathic or not, differ in cardiovascular risk profile at a 
young age compared with women with no miscarriage. Our study 
provides intriguing data which support the need for more research 
to find out whether women with a history of RM should be offered 
screening and counseling for cardiovascular risk factors.
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